PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 67 results · Dermatology  · Clear
🔒 Subscribers only
AUTH/3263/11/19
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Almirall website claims for Ilumetri
An anonymous, non-contactable complainant challenged Almirall’s promotional website (Almirallmed.co.uk) for Ilumetri (tildrakizumab), alleging misleading dosing/efficacy claims and that POM promo…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3447/12/20
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Sanofi
What happened Sanofi made a voluntary admission after discovering that material on www.dupixent.co.uk was not certified. The material was a Sanofi document referring to Dupixent (dupilumab) and NIC…
Clauses: 14.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3431/11/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan
What happened \n \n A doctor practising in aesthetics complained that Allergan employees had ‘liked’, commented on, and shared third-party social media posts (LinkedIn and Instagram) that refer…
Clauses: 2,26.1,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3017/2/18
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Celgene ‘meetings in a box’ materials
An anonymous, contactable complainant alleged Celgene UK used “meetings in a box” materials for Otezla (apremilast) without proper certification/approval and that senior leadership tried to rep…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2831/4/16
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Celgene
Celgene made a voluntary admission after an internal alert that a promotional meeting invitation for Otezla (apremilast) had been sent to a Celgene employee’s personal email address (the employee…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2794/9/15
Off-label Promotion Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Bayer v Actavis
Bayer complained about a four-page Levosert leavepiece (ref UK/LE/0001/01-15b) issued by Actavis UK Ltd.The leavepiece headline asked: “Can a single IUS be suitable for so many women?”The leave…
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2778/7/15
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Ipsen
Merz complained about two Ipsen leavepieces promoting Dysport (botulinum toxin type A) that discussed dose ratios versus other BoNT-A products (including Xeomin and Botox).Leavepiece 1 (ref UK/DYS0…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2767/5/15
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo
A complaint was considered under Paragraph 5.1 by the Director against Leo.The subject matter related to clinical trial disclosure for Picato.The PMCPA determined the matter was outwith the scope o…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2596/4/13
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharma
Almirall alleged two Leo Pharma advertisements for Picato (ingenol mebutate) gel breached an undertaking given by Leo in an earlier case (Case AUTH/2583/3/13).The ads appeared in multiple medical p…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2583/3/13
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharma Picato
Almirall complained about a Leo Pharma journal advertisement for Picato (ingenol mebutate) gel published in the BMJ (26 January 2013).The ad headline stated: “Picato Announcing the arrival of... …
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2633/8/13
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharma
A medicines management pharmacist complained about Leo Pharma promotional material for Picato gel (ingenol mebutate): a pad of 30 pre-printed A4 forms (ref 4340a/000526).The form was a pre-printed …
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2685/12/13
HCP Hospitality & Meetings Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Galderma educational day required delegates to buy Emervel to attend; off-label toxin content and la
An anonymous registered nurse complained about an aesthetics “educational day” run with a nurse support group, described in emails as a “Galderma educational day”.The agenda included conten…
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2487/3/12
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan
Merz alleged Allergan again made disparaging/misleading/unbalanced comparative claims about botulinum toxin potency/efficacy: Vistabel/Botox (onabotulinumtoxinA) vs Bocouture/Xeomin (incobotulinumt…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2496/4/12
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Merz
Allergan complained about three Merz advertisements for Xeomin/Bocouture (botulinum neurotoxin type A) comparing them with Allergan’s Botox/Vistabel.The ads used claims such as “Equipotent”, …
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2503/5/12
Data & Publications Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Genus Pharmaceuticals breached Clause 9.2 over “sexual/titillating” Cetraben ad imagery (AUTH/2503/5
A general practitioner complained about a Genus Pharmaceuticals advertisement for Cetraben (white soft paraffin, light liquid paraffin) published in GP on 25 April 2012 (ref CET04121348B).The ad sh…
Clauses: 9.2
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2515/6/12
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Merz
Allergan complained about Merz Pharma UK’s promotion of Bocouture (botulinum toxin type A) at the FACE Conference and Exhibition (June 2012).Materials at issue: a Merz exhibition stand (ref 1149/…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2460/11/11
HCP Hospitality & Meetings Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan publicly reprimanded after repeated breach of undertaking on botulinum toxin potency messag
Merz alleged Allergan continued to misrepresent comparative potency between Vistabel/Botox (onabotulinumtoxinA) and Bocouture/Xeomin (incobotulinumtoxinA), despite prior undertakings in AUTH/2183/1…
Clauses: 3.2,9.1
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2383/2/11
Off-label Promotion Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable GP complained about a Yasmin (ethinylestradiol/drospirenone) journal advertisement published in Pulse (26 January 2011) by Bayer Healthcare.The ad headline and brandin…
Clauses: 4.1,4.3
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2418/7/11
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Astellas Pharma
A pharmacist complained about a Protopic (tacrolimus) promotional leavepiece (ref: PRO11003UK) issued by Astellas Pharma Ltd.The front cover headline stated: “142 days without a major eczema flar…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2415/6/11
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Biogen Idec
Leo Pharma alerted the PMCPA that a Biogen Idec Tysabri (natalizumab) DVD included a 54-second clip demonstrating Leo’s Xamiol Gel (calcipotriol/betamethasone) on psoriasis.The DVD was intended f…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2413/6/11
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo
Leo became aware (15 June 2011) that a promotional film clip showing application of Xamiol Gel (calcipotriol/betamethasone) for scalp psoriasis had been inadvertently included on a Biogen Idec Tysa…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2465/12/11
HCP Hospitality & Meetings Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Astellas breached Clause 7.2 after Qutenza ‘consensus statement’ insert implied independent/NICE-bac
A prescribing support pharmacist at a PCT complained about a loose insert for Qutenza (capsaicin patch) placed in Guidelines in Practice (Nov 2011); an electronic version was also available to subs…
Clauses: 7.2
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2375/12/10
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
GlaxoSmithKline Consumer Healthcare
Curaprox made a complaint against GlaxoSmithKline Consumer Healthcare.The material referenced was a “Corsodyl Mint Mouthwash detail aid”.The PMCPA concluded the case was outwith the scope of th…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2304/3/10
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Doctor v Forest Laboratories (AUTH/2304/3/10)
A doctor complained about a medical journal advertisement for Exorex Lotion (coal tar solution 5% v/w cutaneous emulsion) by Forest Laboratories UK Limited.The ad showed a young woman walking throu…
Clauses: NONE
2010 🔒 Subscribe
← Prev 1 2 3 Next → Page 2 of 3 — 67 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews